Illumina (MEX:ILMN) Cyclically Adjusted Revenue per Share: MXN476.78 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ILMN Illumina Inc MEX:ILMN
57 GF Score
Price MXN3,375.00
GF Value MXN2,165.86
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Illumina Cyclically Adjusted Revenue per Share?

Illumina MEX:ILMN -4.53% 57 Cyclically Adjusted Revenue per Share is MXN476.78 as of Jun. 2026. GuruFocus rates MEX:ILMN with a GF Score™ of 57/100 and a GF Value™ of MXN2,165.86 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Illumina's adjusted revenue per share for the three months ended in Jun. 2026 was MXN132.179. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN476.78 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Illumina's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Illumina was 33.20% per year. The lowest was 7.50% per year. And the median was 17.85% per year.

As of today (2026-08-01), Illumina's current stock price is MXN3375.00. Illumina's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN476.78. Illumina's Cyclically Adjusted PS Ratio of today is 7.08.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Illumina was 29.44. The lowest was 2.57. And the median was 17.01.


Illumina  (MEX:ILMN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Illumina's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3375.00/476.78
=7.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Illumina was 29.44. The lowest was 2.57. And the median was 17.01.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Illumina Cyclically Adjusted Revenue per Share Related Terms


Illumina Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Illumina's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina Cyclically Adjusted Revenue per Share Chart

Illumina Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 415.40 421.25 430.88 566.94 522.97

Illumina Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 507.41 541.12 522.97 527.97 476.78

MEX:ILMN vs MTD, DGX, LH: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Illumina's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Illumina's Cyclically Adjusted PS Ratio falls into.


MEX:ILMN
57GF Score
Illumina Inc MEX:ILMN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Illumina Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Illumina's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=132.179/333.9520*333.9520
=132.179

Current CPI (Jun. 2026) = 333.9520.

Illumina Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 79.302 241.428 109.693
201612 86.229 241.432 119.273
201703 76.597 243.801 104.920
201706 81.403 244.955 110.978
201709 87.552 246.819 118.460
201712 103.107 246.524 139.673
201803 95.994 249.554 128.459
201806 110.197 251.989 146.040
201809 107.083 252.439 141.660
201812 111.997 251.233 148.872
201903 110.139 254.202 144.693
201906 108.034 256.143 140.852
201909 120.986 256.759 157.360
201912 120.501 256.974 156.598
202003 136.093 258.115 176.079
202006 98.723 257.797 127.886
202009 118.515 260.280 152.061
202012 128.088 260.474 164.221
202103 151.986 264.877 191.621
202106 152.477 271.696 187.415
202109 148.907 274.310 181.283
202112 156.664 278.802 187.654
202203 153.152 287.504 177.895
202206 148.899 296.311 167.814
202209 142.855 296.808 160.733
202212 134.485 296.797 151.321
202303 124.007 301.836 137.202
202306 127.603 305.109 139.666
202309 123.365 307.789 133.851
202312 120.539 306.746 131.230
202403 112.312 312.332 120.086
202406 128.126 314.175 136.191
202409 132.910 315.301 140.772
202412 144.809 315.605 153.227
202503 133.943 319.799 139.871
202506 127.007 322.561 131.492
202509 129.124 324.800 132.762
202512 136.396 324.054 140.562
202603 127.751 330.213 129.198
202606 132.179 333.952 132.179

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN476.78 mean?
Illumina (MEX:ILMN) has a Cyclically Adjusted Revenue per Share of MXN476.78 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Illumina and its competitors.
Is Illumina's Cyclically Adjusted Revenue per Share too high?
Illumina's current Cyclically Adjusted Revenue per Share is MXN476.78. Overall, Illumina has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Illumina's Cyclically Adjusted Revenue per Share compare to MTD and DGX?
Illumina's Cyclically Adjusted Revenue per Share of MXN476.78 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Illumina and its competitors. Illumina's current Cyclically Adjusted Revenue per Share is MXN476.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Illumina stock overvalued right now?
Based on GuruFocus' analysis, Illumina (MEX:ILMN) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN2,165.86, compared to a current price of MXN3,375.00 — trading 55.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN476.78. Illumina's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Illumina (MEX:ILMN), the current Cyclically Adjusted Revenue per Share is MXN476.78 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Illumina (MEX:ILMN) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of MXN3,375.00 is trading 55.8% above its estimated GF Value™ of MXN2,165.86. GuruFocus considers Illumina to be Significantly Overvalued.

Key valuation signals for MEX:ILMN:

  • Cyclically Adjusted Revenue per Share: MXN476.78
  • GF Value™: MXN2,165.86 vs. price of MXN3,375.00 (55.8% above fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the MEX:ILMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
57GF Score

Get the complete analysis for MEX:ILMN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,375.00
Price
MXN2,165.86
GF Value